Large-scale testing (Phase 3)Study completedNCT00658775
What this trial is testing
Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Eisai Inc. 1,069